Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05050643 · ClinicalTrials.gov registry record · NA
High-Risk Veteran Initiative
A NA study of Multimorbidity, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 3
- Study locations
NCT05050643: Active NA study of Multimorbidity, sponsored by VA Office of Research and Development.
NCT05050643 is a NA study of Multimorbidity that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 17 participants, below the 1,347-participant average among 5 other Multimorbidity trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05050643, a NA study of Multimorbidity, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 3
- Study locations
Study Summary
Veterans at high-risk for hospitalization, including those with complex care needs, represent a large population of VHA patients who often do not receive evidence-based primary care practices that would help them avoid the hospital and improve their health. The high-RIsk VETerans (RIVET) Program will implement evidence-based practices that can support VHA Primary Care teams to deliver more comprehensive and patient-centered care, better strategies to manage medications, and avoid unnecessary hospitalizations. The RIVET Program is designed to find the most effective approaches to increasing use of evidence-based practices for high-risk Veterans in primary care, provide rapid data feedback to VHA on high-risk patient care, build capacity for the implementation of evidence-based practices, and train future leaders in high-risk Veteran care.
Primary Outcome
This primary outcome aims to measure reach of the evidence practices to implement the EBP.
Conditions Studied
Interventions
- OTHER EBQI-IC
- OTHER EBQI-LC
Study Locations (3)
California
- VA Greater Los Angeles Healthcare System, Sepulveda, CA - Sepulveda
Pennsylvania
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-07-23 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What the registry record for NCT05050643 still lists
NCT05050643 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,347-participant average among 5 other Multimorbidity trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Multimorbidity appearing as the primary indexed condition, and to 2 interventions - of which EBQI-IC is the first listed.
NCT05050643 reports a single indexed study location in California, Pennsylvania, Washington.
Frequently Asked Questions
What is clinical trial NCT05050643 about?
NCT05050643 is a clinical study titled "High-Risk Veteran Initiative". Veterans at high-risk for hospitalization, including those with complex care needs, represent a large population of VHA patients who often do not receive evidence-based primary care practices that would help them avoid the hospital and improve their health. The high-RIsk VETerans (RIVET) Program wil...
What is the current status of trial NCT05050643?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2021-07-23. Estimated completion is 2026-12-30.
What conditions does trial NCT05050643 study?
This clinical trial studies the following conditions: Multimorbidity.
What interventions are being tested in trial NCT05050643?
The interventions under investigation include: EBQI-IC (OTHER), EBQI-LC (OTHER).
Who is sponsoring clinical trial NCT05050643?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05050643 being conducted?
This trial has 3 study locations across California, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multimorbidity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Multicomponent Telerehabilitation to Engage Veterans in Effective Self-Management of Complex Health Conditions
RECRUITING · NA
-
Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions
RECRUITING · NA
-
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
RECRUITING · NA
-
Telehealth-delivered Peer Support to Improve Quality of Life Among Veterans With Multimorbidity
ACTIVE NOT RECRUITING · NA
-
Video-Enhanced Care Management for Medically Complex Veterans
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI